Amplia CEO and Managing Director, Dr John Lambert, has been featured in an ABCNews article ahead of his presentation at the 16th Bioshares Biotech Summit to be hosted in Albury from 11-12 May 2022.
He comments on Amplia’s upcoming milestone - the commencement of our Phase 2 clinical trial of AMP945 in first-line pancreatic cancer patients - and how eligible patients can advocate for their involvement, regardless of where they call home.
Read the article
